Cancer Center Support Grant

癌症中心支持补助金

• 批准号: 8907926
• 负责人: ROY A. JENSEN
• 金额: $ 151万
• 依托单位: UNIVERSITY OF KANSAS MEDICAL CENTER
• 依托单位国家: 美国
• 财政年份: 2012
• 资助国家: 美国
• 起止时间: 2012-07-11 至 2016-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8907926
• 关键词: Academia; Accounting; Adoption; Agreement; American; Antineoplastic Agents; Area; Biostatistics Shared Resource; Cancer Biology; Cancer Center; Cancer Center Support Grant; Cancer Control; Cancer Patient; Cancer Research Project; Catchment Area; Cities; Clinical; Clinical Research; Clinical Trials; Communities; Development; Diagnosis; Disease; Doctor of Medicine; Ensure; Environment; Family; Fostering; Funding; Goals; Government; Industry; Informatics; Institutes; Institution; Kansas; Laboratories; Lead; Leadership; Life; Malignant Neoplasms; Medical Research; Medical center; NCI Center for Cancer Research; NCI-Designated Cancer Center; Oncologist; Pharmacotherapy; Phase I Clinical Trials; Positioning Attribute; Recruitment Activity; Research; Research Personnel; Resource Sharing; Secure; Services; Technology; Therapeutic; Universities; Wichita; base; cancer prevention; drug discovery; fight against; implementation research; improved; meetings; member; novel therapeutic intervention; novel therapeutics; oncology; population based; population health; programs; survivorship

DESCRIPTION (provided by applicant): The University of Kansas Cancer Center (KUCC) is a matrix cancer center that includes: the University of Kansas Medical Center campuses in Kansas City and Wichita, the University of Kansas-Lawrence, and the Stowers Institute for Medical Research (via consortium agreement). In 2010, 143 members of KUCC accounted for $11.4 million of NCI funding and a total of $55.1 million in overall cancer-related funding. KUCC is led by Roy A. Jensen, M.D. who is supported by a strong, nationally recognized leadership team. Over the last seven years substantial progress has been made securing institutional commitment, recruiting key leadership positions, building nationally significant research programs, developing our clinical research program, improving and expanding our facilities, and creating transdisciplinary and collaborative interactions. With input from our External Advisory Board, we have established three goals for KUCC that will insure we make a national impact in the fight against cancer: Goal 1: Become the leading academic institution for transforming discoveries from the laboratory into new anticancer drug therapies. Goal 2: Provide the optimal environment for basic, translational, clinical, and population-based research in oncology by developing and fostering a collaborative, collegial, and dynamic culture of scientific inquiry. Goal 3: Be a nationally recognized leader in partnering with community oncologists and other key stakeholders to develop, promote, and foster the adoption and implementation of research-based cancer prevention, diagnosis, treatment, control, and survivorship practices throughout our service area. To accomplish these goals KUCC has four research programs including: Cancer Biology, Cancer Control and Population Health, Cancer Prevention, and Drug Discovery, Delivery and Experimental Therapeutics. In addition, the Cancer Center supports four shared resources: Biostatistics and Informatics, Lead Development and Optimization, Biospecimen, and Clinical Trials Management.

描述（由申请人提供）：堪萨斯大学癌症中心（KUCC）是一个基质癌症中心，其中包括：堪萨斯城的堪萨斯大学医学中心校园和威奇托，堪萨斯大学法律大学和斯托尔斯大学医学研究所（通过协定）。 2010年，KUCC的143名成员占NCI资金的1,140万美元，总计5510万美元的总体癌症相关资金。 KUCC由医学博士Roy A. Jensen领导，他得到了一个由全国认可的强大领导团队的支持。在过去的七年中，取得了巨大的进步，确保了机构承诺，招募关键领导职务，建立全国重要的研究计划，制定我们的临床研究计划，改善和扩展我们的设施，并建立跨学科和协作的互动。在我们的外部顾问委员会的意见下，我们为KUCC建立了三个目标，这将确保我们对抗癌斗争产生全国影响： 目标1：成为将实验室发现转化为新抗癌药物疗法的领先学术机构。 目标2：通过开发和培养科学探究的协作，大学和动态文化，为肿瘤学基础，转化，临床和人群研究提供最佳环境。 目标3：成为与社区肿瘤学家和其他主要利益相关者合作的全国认可的领导者，以开发，促进和促进和促进基于研究的癌症预防，诊断，治疗，控制和生存实践的采用和实施。 为了实现这些目标，KUCC有四个研究计划，包括：癌症生物学，癌症控制和人群健康，预防癌症以及药物发现，分娩和实验性治疗。此外，癌症中心还支持四个共同的资源：生物统计学和信息学，铅开发和优化，生物测试和临床试验管理。